Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 163

    1.

    Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

    Thrailkill KM, Bunn RC, Moreau CS, Cockrell GE, Simpson PM, Coleman HN, Frindik JP, Kemp SF, Fowlkes JL.

    Diabetes Care. 2007 Sep;30(9):2321-6. Epub 2007 Jun 11. Erratum in: Diabetes Care. 2007 Dec;30(12):3154. PMID: 17563344 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes.

    Maxwell PR, Timms PM, Chandran S, Gordon D.

    Diabet Med. 2001 Oct;18(10):777-80.PMID: 11678966 [PubMed - indexed for MEDLINE]Related articles

    3.

    Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy.

    Tashiro K, Koyanagi I, Ohara I, Ito T, Saitoh A, Horikoshi S, Tomino Y.

    J Clin Lab Anal. 2004;18(3):206-10.PMID: 15103687 [PubMed - indexed for MEDLINE]Related articles

    4.

    Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.

    Steinke JM, Mauer M; International Diabetic Nephropathy Study Group.

    Pediatr Endocrinol Rev. 2008 Aug;5 Suppl 4:958-63. Review.PMID: 18806710 [PubMed - indexed for MEDLINE]Related articles

    5.

    Association of diabetic retinopathy and renal function in patients with types 1 and 2 diabetes mellitus.

    Wolf G, Müller N, Mandecka A, Müller UA.

    Clin Nephrol. 2007 Aug;68(2):81-6.PMID: 17722706 [PubMed - indexed for MEDLINE]Related articles

    6.

    Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy.

    Jacqueminet S, Ben Abdesselam O, Chapman MJ, Nicolay N, Foglietti MJ, Grimaldi A, Beaudeux JL.

    Clin Chim Acta. 2006 May;367(1-2):103-7. Epub 2006 Jan 19.PMID: 16426593 [PubMed - indexed for MEDLINE]Related articles

    7.

    Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.

    Rysz J, Banach M, Stolarek RA, Pasnik J, Cialkowska-Rysz A, Koktysz R, Piechota M, Baj Z.

    J Nephrol. 2007 Jul-Aug;20(4):444-52.PMID: 17879211 [PubMed - indexed for MEDLINE]Related articles

    8.

    Urinary excretion of podocytes in patients with diabetic nephropathy.

    Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H.

    Nephrol Dial Transplant. 2000 Sep;15(9):1379-83.PMID: 10978394 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Coronary artery calcification, serum lipids, lipoproteins, and peripheral inflammatory markers in adolescents and young adults with type 1 diabetes.

    Gunczler P, Lanes R, Soros A, Verdu L, Ramon Y, Guevara B, Beer N.

    J Pediatr. 2006 Sep;149(3):320-3.PMID: 16939740 [PubMed - indexed for MEDLINE]Related articles

    10.

    Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy.

    Nguyen TQ, Tarnow L, Andersen S, Hovind P, Parving HH, Goldschmeding R, van Nieuwenhoven FA.

    Diabetes Care. 2006 Jan;29(1):83-8.PMID: 16373901 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effect of acute hyperglycaemia on selected plasma and urinary cytokine antagonists in Type 1 diabetes mellitus.

    Pelikánová T, Simková R, Tesar V, Jirsa M.

    Diabetologia. 2003 Apr;46(4):470-4. Epub 2003 Apr 5.PMID: 12679866 [PubMed - indexed for MEDLINE]Related articles

    12.

    Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus.

    Derosa G, Avanzini MA, Geroldi D, Fogari R, Lorini R, De Silvestri A, Tinelli C, Rondini G, d'Annunzio G.

    Diabetes Res Clin Pract. 2005 Nov;70(2):119-25. Epub 2005 Apr 18.PMID: 16188574 [PubMed - indexed for MEDLINE]Related articles

    13.

    Thailand diabetes registry project: prevalence of vascular complications in long-standing type 2 diabetes.

    Leelawattana R, Pratipanawatr T, Bunnag P, Kosachunhanun N, Suwanwalaikorn S, Krittiyawong S, Chetthakul T, Plengvidhya N, Benjasuratwong Y, Deerochanawong C, Mongkolsomlit S, Ngarmukos C, Rawdaree P.

    J Med Assoc Thai. 2006 Aug;89 Suppl 1:S54-9.PMID: 17717878 [PubMed - indexed for MEDLINE]Related articles

    14.

    Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus.

    Shiau MY, Tsai ST, Tsai KJ, Haung ML, Hsu YT, Chang YH.

    Mt Sinai J Med. 2006 Nov;73(7):1024-8.PMID: 17195891 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy.

    Otu HH, Can H, Spentzos D, Nelson RG, Hanson RL, Looker HC, Knowler WC, Monroy M, Libermann TA, Karumanchi SA, Thadhani R.

    Diabetes Care. 2007 Mar;30(3):638-43.PMID: 17327333 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.

    Derosa G, D'Angelo A, Scalise F, Avanzini MA, Tinelli C, Peros E, Fogari E, Cicero AF.

    Heart Vessels. 2007 Nov;22(6):361-70. Epub 2007 Nov 26.PMID: 18043992 [PubMed - indexed for MEDLINE]Related articles

    17.

    Microalbuminuria and clinical correlates in black African patients with type 2 diabetes.

    Adetunji OR, Adeleye JO, Agada NO, Salako BL.

    West Afr J Med. 2006 Oct-Dec;25(4):279-83.PMID: 17402516 [PubMed - indexed for MEDLINE]Related articles

    18.

    Increased matrix metalloproteinase 2 activity in the human internal mammary artery is associated with ageing, hypertension, diabetes and kidney dysfunction.

    Chung AW, Booth AD, Rose C, Thompson CR, Levin A, van Breemen C.

    J Vasc Res. 2008;45(4):357-62. Epub 2008 Mar 10.PMID: 18332634 [PubMed - indexed for MEDLINE]Related articles

    19.

    Survey on acute and chronic complications in children and adolescents with type 1 diabetes at Muhimbili National Hospital in Dar es Salaam, Tanzania.

    Majaliwa ES, Munubhi E, Ramaiya K, Mpembeni R, Sanyiwa A, Mohn A, Chiarelli F.

    Diabetes Care. 2007 Sep;30(9):2187-92. Epub 2007 Jun 11.PMID: 17563337 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    MT1-MMP expression in first-trimester placental tissue is upregulated in type 1 diabetes as a result of elevated insulin and tumor necrosis factor-alpha levels.

    Hiden U, Glitzner E, Ivanisevic M, Djelmis J, Wadsack C, Lang U, Desoye G.

    Diabetes. 2008 Jan;57(1):150-7. Epub 2007 Oct 10.PMID: 17928399 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data